✦ LIBER ✦

Radiosynthesis of [tetrazoyl-11C]irbesartan, a non-peptidic angiotensin II antagonist

✍ Scribed by M Ponchant; S Demphel; F Hinnen; C Crouzel

Book ID: 108422153
Publisher: Elsevier Science
Year: 1997
Tongue: French
Weight: 631 KB
Volume: 32
Category: Article
ISSN: 0223-5234
DOI: 10.1016/s0223-5234(97)88917-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Radiosynthesis of (

ChemInform Abstract: Radiosynthesis of (Tetrazoyl-11C)irbesartan, a Non-Peptidic Angiotensin II Antagonist.

✍ M. PONCHANT; S. DEMPHEL; F. HINNEN; C. CROUZEL 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 28 KB 👁 2 views

Radiosynthesis of (Tetrazoyl-11C)irbesartan, a Non-Peptidic Angiotensin II Antagonist. -A one-pot procedure for labeling the tetrazole moiety is developed. The resulting irbesartan (V) is not suitable for studying myocardial angiotensin II receptor with positron-emission tomography. -(

Bromobenzofurans : a new class of potent

Bromobenzofurans : a new class of potent, non-peptide antagonists of angiotensin II

✍ D Middlemiss; G.M. Drew; B.C. Ross; M.J. Robertson; D.I.C. Scopes; M.D. Dowle; J 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 370 KB

A Review of the Clinical Experience with

A Review of the Clinical Experience with the Angiotensin II Receptor Antagonist Irbesartan

✍ Waeber, Bernard 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

Efficacy of Irbesartan, a Receptor Selec

Efficacy of Irbesartan, a Receptor Selective Antagonist of Angiotensin II, in Reducing Portal Hypertension

✍ Wilma Debernardi-Venon; Claudio Barletti; Carlo Alessandria; Alfredo Marzano; M. 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 192 KB

Development of [11C]L-159,884: A radiola

Development of [11C]L-159,884: A radiolabelled, nonpeptide angiotensin II antagonist that is useful for angiotensin II, AT1 receptor imaging

✍ Terence G. Hamill; H. Donald Burns; Robert F. Dannals; William B. Mathews; John 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 722 KB

The pharmacokinetics and metabolism of D

The pharmacokinetics and metabolism of DuP 532, a non-peptide angiotensin II receptor antagonist, in rats and dogs

✍ Y. N. Wong; K. A. Holm; D. L. Burcham; S.-M. Huang; C. Y. Quon 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 1 views

DuP 532, 2-propy1-4-pentafluoroethyl-l-[ [2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methylJ imidazole-5-carboxylic acid, is an orally active, non-peptide angiotensin I1 (AII) receptor antagonist. DuP 532 is more potent and longer acting than losartan, another A11 receptor antagonist currently undergoing ph